Elevated vascular reactivity in the timolol-treated spontaneously hypertensive rat

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Hypertension Research

Background:

• Spontaneously hypertensive rats (SHR) are a model for human essential hypertension.
• Vascular smooth muscle (VSM) hyperreactivity is a hallmark of hypertension.
• The role of cellular defects in hypertension initiation is not fully understood.

Purpose of the Study:

• To investigate the role of cellular mechanisms in the development of hypertension in SHR.
• To determine if early intervention with timolol prevents hypertension and alters VSM reactivity.
• To explore potential membrane or cellular defects contributing to enhanced VSM responsiveness in SHR.

Main Methods:

• In utero and post-weaning oral administration of timolol (a beta-adrenergic blocker) to SHR.
• Measurement of blood pressure in treated and control rats.
• Assessment of isolated aortic ring reactivity to potassium (K+) and calcium (Ca2+) in normotensive and hypertensive rat models.

Main Results:

• Timolol treatment prevented the development of hypertension in SHR.
• Aortic rings from normotensive, timolol-treated SHR exhibited increased reactivity to high extracellular K+ compared to control WKY rats.
• Normotensive SHR aorta showed responsiveness to H+ and high Ca2+ without prior K+ depolarization.

Conclusions:

• The prevention of hypertension by timolol suggests that factors beyond elevated peripheral resistance contribute to its initiation.
• Increased vascular smooth muscle reactivity in SHR may stem from a membrane or cellular defect facilitating Ca2+ availability.
• This defect potentially influences Ca2+ handling in vascular smooth muscle cells, contributing to hypertension development.